Navigation Links
Safe Options for Cardiac Lead Removal: Study Published in Heart Rhythm Journal

Spectranetics' Laser System Successfully Assists Removal of 975 Cardiac


COLORADO SPRINGS, Colo., May 12 /PRNewswire-FirstCall/ -- Spectranetics Corporation (Nasdaq: SPNC) today announced that a peer-reviewed study demonstrates Spectranetics' excimer laser sheath safely and effectively assists removal of pacing and defibrillator leads. The study, "Large, Single- catheter, Single-operator Experience with Transvenous Lead Extraction: Outcomes and Changing Indications," featured in the April issue of HeartRhythm, represents a seven year retrospective analysis of data from 498 lead extraction procedures involving 975 leads. The conclusion demonstrates safe extraction of leads successfully removed with laser assistance. HeartRhythm is the official journal of the Heart Rhythm Society and the Cardiac Electrophysiology Society.

As an escalating number of patients receive implanted cardiac devices, concerns surrounding lead management options are on the rise. Infection continues to be a primary cause for concern with leads, however, lead malfunction and patient lifespan are increasingly encouraging physicians to consider lead removal versus lead abandonment, the previous standard-of-care practice. Historically, safe, effective technologies designed to assist lead removal were limited but this is changing as new technologies enter the market and continue to receive clinical validation.

The Spectranetics Laser Sheath (SLS(R) II) use "cool" ultraviolet light to safely, effectively and efficiently ablate scar tissue that holds problematic leads in place. A circle of fibers that emit pulses of energy travel over the cardiac lead towards the tip to dissolve scar tissue that binds the lead to the body. Once the scar tissue is dissolved, the lead can be safely removed. Spectranetics' Lead Locking Device (LLD) technology can also be used to assist removal by creating secure traction during procedures that may or may not require laser assistance.

The retrospective study at Brigham and Women's Hospital in Boston was designed to examine indications, outcomes and complications associated with transvenous lead extraction. Dr. Laurence Epstein, Chief of Cardiac Arrhythmia Services at Brigham and Women's Hospital acted as the single-operator in the study handling all 498 lead extraction procedures throughout the seven year period. The study showed a success rate of over 97% with only two major complications, and no deaths. These two major complications out of 498 procedures resulted in a major complication rate of only 0.4%. The published article also highlights concerns surrounding existing formal recommendations for lead removal given the technologies available to assist the process. The article notes that "the rate of complications from abandoned leads reported in one study was as low as 5.5 percent, which still is higher than the complication rate from extraction."

"We were interested in reviewing our outcomes, at a high volume center with an experienced operator," said Dr. Epstein. "Historically the indications for lead extraction have been tempered by the risks, real and perceived, associated with the procedure. This study demonstrates that transvenous lead extraction can be performed safely and effectively in a wider population of patients." Dr. Epstein further describes his strategy, explaining, "Hopefully, this will reduce the number of patients subjected to open heart procedures and the risks and complications of abandoned leads. However, this is not an endorsement for the performance of extraction, more widely, in inexperienced hands. Excellent results are achieved through careful preparation, planning and experience."

About Spectranetics

Founded in 1984, Spectranetics manufactures and sells the only excimer laser approved in the United States, Europe and Japan for use in minimally invasive cardiovascular procedures. This technology treats complex cardiovascular conditions by photo-ablating multiple lesion types into tiny particles that are easily absorbed into the blood stream. The Company's disposable catheters use high-energy "cool" ultraviolet light to vaporize arterial blockages in the legs and heart, as well as scar tissue encapsulating pacing and defibrillation leads. For more information, visit

Stacey Holifield/Krystin Hayward

Schwartz Communications, Inc.,

(781) 684-0770

SOURCE Spectranetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ValueOptions(R) New Mexico Provides $10.3 Million for Community Behavioral Health Care Organizations
2. Keith Denner Extends Current Technologys Chairman and CEO Options
3. SNAPforSeniors Now Helps BenefitsCheckUp Users Locate Housing Options
4. Blue Cross Consumer-directed Health Plan - Options Blue - Members Not Sacrificing Health for the Sake of Saving Money
5. Guardian Expands Dental Benefit Options Helps Small Business Owners Lower Insurance Cost
6. NeurogesX to Present at Susquehanna Financial Groups 2nd Annual SIGnificant Options in Healthcare Conference
7. Novavax CEO to Present at Susquehannas Second SIGnificant Options in Healthcare Conference
8. Abaxis, Inc. to Present at the Susquehanna Financial Groups Second Annual SIGnificant Options in Healthcare Conference
9. Idenix Pharmaceuticals to Present at the SIGnificant Investment Options in Healthcare Conference
10. Advanced Life Sciences to Present at Susquehannas Second Annual SIGnificant Investment Options in Healthcare Conference
11. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... Chiropractic ... University-Kansas City (CU-KC), in Overland Park, Kansas. Benson, a fifth-trimester student in ... Carl S. Cleveland III on October 16. , “Katie is very excited and ...
(Date:11/24/2015)... ... November 24, 2015 , ... Sir Grout of Baltimore ... TrustDale certification. The award recognizes good companies for excellence in service and a ... grout, and hard surface restoration company earned this recognition after a thorough review ...
(Date:11/24/2015)... ... 2015 , ... Bibliomotion is thrilled to announce the launch of ... Diversity by Nancy M. Schlichting, Chief Executive Officer of Henry Ford Health ... the needs of patients and their families, shaped my desire to improve the system ...
(Date:11/24/2015)... ... November 24, 2015 , ... Dr. Kevin Day, local family ... community stress less this holiday season. During the Indiana winter months, Vitamin D ... and the team at AlignLife want to help provide the tools needed to combat ...
(Date:11/24/2015)... ... November 24, 2015 , ... All her life, Don Peck’s mother wondered if she was a ... might have been. After a 25-year search for information, Don and his aunt discovered ... a last name. Turns out, it was Don’s father who was descended from not ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... 24, 2015  Boston Scientific Corporation (NYSE: BSX ... Annual Healthcare Conference on December 8, in ... , vice president, Investor Relations, will participate in a ... approximately 8:35 a.m. ET. --> Susie Lisa ... 30-minute question-and-answer session with the host analyst beginning at ...
(Date:11/24/2015)... Nov. 24, 2015  Enova Illumination is pleased to ... Helsinki, Finland to combine their world ... the cutting edge of medical visualization: Enova is the ... the United States and Novocam is the ... provide the world,s most powerful battery-operated LED headlight with ...
(Date:11/24/2015)... -based Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY ... production and dispensing of novel compounded pharmaceuticals.  The ... including ophthalmology, urology, sinus and integrative medicine.  Imprimis ... four facilities located in California ... New Jersey and Pennsylvania.  For more ...
Breaking Medicine Technology: